Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 30, 2025 12:17 ET | Source: KuicK Research

Kuick Research Report Maps Next Wave Of M&A Opportunities In Global Cancer Antibodies Drug Conjugates Market

Delhi, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Kuick Research has unveiled its latest comprehensive report on the Global Cancer Antibody Drug Conjugate (ADC) Market, a 1300 page study that serves as a...
August 06, 2025 04:22 ET | Source: Research and Markets

Cancer Antibody Drug Conjugates Market Research 2025-2031 | Pfizer, AstraZeneca, and Biotechs Like Miracogen Advance Cancer ADCs with Strategic Acquisitions and Innovative Pipelines

Dublin, Aug. 06, 2025 (GLOBE NEWSWIRE) -- The "Cancer Antibody Drug Conjugates Market Opportunity, Patent, Price, Approved Drug Sales & Clinical Trials Insight 2031" report has been added to ...
July 11, 2025 14:16 ET | Source: KuicK Research

Cancer Antibody Drug Conjugates Treatment Market Size Clinical Trials FDA Approved Report

Delhi, July 11, 2025 (GLOBE NEWSWIRE) -- Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales and Clinical Trials Insight 2030 Report Finding & Inclusions: Global...
March 24, 2025 05:01 ET | Source: Research and Markets

Global Cancer Antibody Drug Conjugates Market Landscape 2024-2030 Featuring Biocytogen, Merck, AstraZeneca, Pfizer, Daiichi Sankyo, and ADC Therapeutics

Dublin, March 24, 2025 (GLOBE NEWSWIRE) -- The "Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030" report has been added to ...
December 18, 2024 05:49 ET | Source: Research and Markets

Urothelial Cancer Drugs Markets and Competitive Landscape Analysis, 2024-2030, Featuring Profiles of 42 Major Companies, Including AstraZeneca, Bristol-Myers Squibb, Celgene Corporation, and Eli Lilly & Co

Dublin, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The "Urothelial Cancer Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
October 31, 2024 12:57 ET | Source: Research and Markets

Cancer Antibody Drug Conjugates Market, Drugs Approval & Clinical Trials Report 2024 - A US$ 50 Billion+ Market Opportunity By 2030

Dublin, Oct. 31, 2024 (GLOBE NEWSWIRE) -- The "Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030" report has been added to ...
October 22, 2024 14:33 ET | Source: KuicK Research

Global Cancer Antibody Drug Conjugates Market Size Forecast 2030

Delhi, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030 Report Finding & Inclusions: Global...
September 19, 2024 07:34 ET | Source: KuicK Research

SKB264 Innovative Cancer Antibody Drug Conjugate Clinical Trials Efficacy Insight

Delhi, Sept. 19, 2024 (GLOBE NEWSWIRE) -- SKB264, also known as MK-2870, is an innovative antibody-drug conjugate (ADC) targeting TROP2, currently being developed by Kelun Biotech in partnership...
August 23, 2023 02:53 ET | Source: KuicK Research

Cancer Antibody Drug Conjugates Market Size Clinical Trials Insight

Delhi, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, & Clinical Trials Outlook 2029 Report Highlights: Global Antibody...
April 28, 2022 09:15 ET | Source: Global Market Estimates

Global Oncology Antibody Drug Conjugates Market Size

Brooklyn, New York, April 28, 2022 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Oncology Antibody Drug Conjugates Market is...